Edition:
India

Novan Inc (NOVN.OQ)

NOVN.OQ on NASDAQ Stock Exchange Global Market

4.48USD
15 Dec 2017
Change (% chg)

$-0.02 (-0.44%)
Prev Close
$4.50
Open
$4.52
Day's High
$4.61
Day's Low
$4.15
Volume
19,745
Avg. Vol
14,187
52-wk High
$28.69
52-wk Low
$3.52

Select another date:

Tue, Dec 5 2017

BRIEF-Novan announces first patient dosed in phase 1B Atopic Dermatitis trial With Sb414

* NOVAN ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B ATOPIC DERMATITIS TRIAL WITH SB414

BRIEF-Novan says ‍agreed to business structure to enable development of SB204 via 3rd party financing and execution

* Novan Inc -‍agreed to business structure to enable development of SB204 via 3rd party financing, 3rd party execution of additional Phase 3 pivotal trial​

BRIEF-Novan acquires IP rights to treat viral malignancies with nitric oxide

* Novan acquires IP rights to treat viral malignancies with nitric oxide

BRIEF-Novan Inc says files for mixed shelf of upto $150 million ‍​

* Novan Inc says files for mixed shelf of upto $150 million - SEC filing‍​ ‍​

BRIEF-Machelle Sanders appointed to Novan board of directors

* Machelle Sanders appointed to Novan board of directors Source text for Eikon: Further company coverage:

BRIEF-Novan conducts guidance meeting with FDA on SB204 development program

* Novan conducts guidance meeting with FDA on SB204 development program

BRIEF-Novan Inc director ‍Robert Ingram reports open market purchase of 12,000 shares of co's common stock - SEC filing​

* Novan Inc director ‍Robert Ingram reports open market purchase of 12,000 shares of co's common stock - SEC filing​

BRIEF-Novan, interim CFO William Hodges enter into an amendment to offer letter

* Novan Inc - on June 28, co and William L. Hodges, interim CFO of company, entered into an amendment to offer letter dated March 21, 2017 - SEC filing

Select another date: